OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A proliferation-inducing ligand (APRIL) induced hyper-production of IgA from tonsillar mononuclear cells in patients with IgA nephropathy
Miki Takahara, Toshihiro Nagato, Yui Nozaki, et al.
Cellular Immunology (2019) Vol. 341, pp. 103925-103925
Open Access | Times Cited: 32
Miki Takahara, Toshihiro Nagato, Yui Nozaki, et al.
Cellular Immunology (2019) Vol. 341, pp. 103925-103925
Open Access | Times Cited: 32
Showing 1-25 of 32 citing articles:
A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy
Mohit Mathur, Jonathan Barratt, Bobby Chacko, et al.
New England Journal of Medicine (2023) Vol. 390, Iss. 1, pp. 20-31
Open Access | Times Cited: 75
Mohit Mathur, Jonathan Barratt, Bobby Chacko, et al.
New England Journal of Medicine (2023) Vol. 390, Iss. 1, pp. 20-31
Open Access | Times Cited: 75
IgA nephropathy
Eleni Stamellou, Claudia Seikrit, Sydney C.W. Tang, et al.
Nature Reviews Disease Primers (2023) Vol. 9, Iss. 1
Closed Access | Times Cited: 64
Eleni Stamellou, Claudia Seikrit, Sydney C.W. Tang, et al.
Nature Reviews Disease Primers (2023) Vol. 9, Iss. 1
Closed Access | Times Cited: 64
IgA Nephropathy: Current Understanding and Perspectives on Pathogenesis and Targeted Treatment
Ya-ting Du, Cheng Tingzhu, Chenxuan Liu, et al.
Diagnostics (2023) Vol. 13, Iss. 2, pp. 303-303
Open Access | Times Cited: 24
Ya-ting Du, Cheng Tingzhu, Chenxuan Liu, et al.
Diagnostics (2023) Vol. 13, Iss. 2, pp. 303-303
Open Access | Times Cited: 24
The Role of Immune Modulation in Pathogenesis of IgA Nephropathy
Sheng Chang, Xiao‐Kang Li
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 63
Sheng Chang, Xiao‐Kang Li
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 63
Perspectives on how mucosal immune responses, infections and gut microbiome shape IgA nephropathy and future therapies
Jiawei He, Shu‐Feng Zhou, Jicheng Lv, et al.
Theranostics (2020) Vol. 10, Iss. 25, pp. 11462-11478
Open Access | Times Cited: 61
Jiawei He, Shu‐Feng Zhou, Jicheng Lv, et al.
Theranostics (2020) Vol. 10, Iss. 25, pp. 11462-11478
Open Access | Times Cited: 61
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VIS649 (Sibeprenlimab), an APRIL-Neutralizing IgG2 Monoclonal Antibody, in Healthy Volunteers
Mohit Mathur, Jonathan Barratt, Yusuke Suzuki, et al.
Kidney International Reports (2022) Vol. 7, Iss. 5, pp. 993-1003
Open Access | Times Cited: 31
Mohit Mathur, Jonathan Barratt, Yusuke Suzuki, et al.
Kidney International Reports (2022) Vol. 7, Iss. 5, pp. 993-1003
Open Access | Times Cited: 31
Prevention and Treatment of IgA Nephropathy Based on Lung-Intestinal Axis and Mucosal Immunity
静 王
Advances in Clinical Medicine (2025) Vol. 15, Iss. 01, pp. 296-303
Closed Access
静 王
Advances in Clinical Medicine (2025) Vol. 15, Iss. 01, pp. 296-303
Closed Access
The Role of Mucosal Immunity: What Can We Learn From Animal and Human Studies?
Patrick J. Gleeson, Renato C. Monteiro
Seminars in Nephrology (2025), pp. 151566-151566
Closed Access
Patrick J. Gleeson, Renato C. Monteiro
Seminars in Nephrology (2025), pp. 151566-151566
Closed Access
Emerging Biochemical and Immunologic Mechanisms in the Pathogenesis of IgA Nephropathy
Jan Novák, Colin Reily, Nicholas J. Steers, et al.
Seminars in Nephrology (2025), pp. 151565-151565
Closed Access
Jan Novák, Colin Reily, Nicholas J. Steers, et al.
Seminars in Nephrology (2025), pp. 151565-151565
Closed Access
An Update on Targeted Treatment of IgA Nephropathy: An Autoimmune Perspective
Xin Huang, Gaosi Xu
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 31
Xin Huang, Gaosi Xu
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 31
Role of Palatine Tonsil and Epipharyngeal Lymphoid Tissue in the Development of Glomerular Active Lesions (Glomerular vasculitis) in Immunoglobulin A Nephropathy
Osamu Hotta, Norio Ieiri, Masaaki Nagai, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 727-727
Open Access | Times Cited: 17
Osamu Hotta, Norio Ieiri, Masaaki Nagai, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 727-727
Open Access | Times Cited: 17
New Insights into the Treatment of Glomerular Diseases: When Mechanisms Become Vivid
Da-Wei Lin, Cheng‐Chih Chang, Yung‐Chien Hsu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3525-3525
Open Access | Times Cited: 14
Da-Wei Lin, Cheng‐Chih Chang, Yung‐Chien Hsu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3525-3525
Open Access | Times Cited: 14
Role of the APRIL molecule in solid tumors
K. Nowacka, Ewa Jabłońska
Cytokine & Growth Factor Reviews (2021) Vol. 61, pp. 38-44
Open Access | Times Cited: 18
K. Nowacka, Ewa Jabłońska
Cytokine & Growth Factor Reviews (2021) Vol. 61, pp. 38-44
Open Access | Times Cited: 18
microRNA-630 Regulates Underglycosylated IgA1 Production in the Tonsils by Targeting TLR4 in IgA Nephropathy
Chan Liu, Muyao Ye, Wenzhe Yan, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 17
Chan Liu, Muyao Ye, Wenzhe Yan, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 17
Cytokines and Production of AberrantlyO-Glycosylated IgA1, the Main Autoantigen in IgA Nephropathy
Taylor Person, R. Glenn King, Dana V. Rizk, et al.
Journal of Interferon & Cytokine Research (2022) Vol. 42, Iss. 7, pp. 301-315
Open Access | Times Cited: 9
Taylor Person, R. Glenn King, Dana V. Rizk, et al.
Journal of Interferon & Cytokine Research (2022) Vol. 42, Iss. 7, pp. 301-315
Open Access | Times Cited: 9
Prognosis of IgA Nephropathy with Stages 3b-5 CKD
Zhanfei Wu, Hongfen Li, Youxia Liu, et al.
Kidney & Blood Pressure Research (2024) Vol. 49, Iss. 1, pp. 273-285
Open Access | Times Cited: 1
Zhanfei Wu, Hongfen Li, Youxia Liu, et al.
Kidney & Blood Pressure Research (2024) Vol. 49, Iss. 1, pp. 273-285
Open Access | Times Cited: 1
LIF/JAK2/STAT1 Signaling Enhances Production of Galactose-Deficient IgA1 by IgA1-Producing Cell Lines Derived From Tonsils of Patients With IgA Nephropathy
Koshi Yamada, Zhiqiang Huang, Colin Reily, et al.
Kidney International Reports (2023) Vol. 9, Iss. 2, pp. 423-435
Open Access | Times Cited: 4
Koshi Yamada, Zhiqiang Huang, Colin Reily, et al.
Kidney International Reports (2023) Vol. 9, Iss. 2, pp. 423-435
Open Access | Times Cited: 4
T lymphocytes in IgA nephropathy (Review)
Yuyan Tang, Haidong He, Pin Jin Hu, et al.
Experimental and Therapeutic Medicine (2020)
Open Access | Times Cited: 12
Yuyan Tang, Haidong He, Pin Jin Hu, et al.
Experimental and Therapeutic Medicine (2020)
Open Access | Times Cited: 12
Polyclonal B‐cell lymphocytosis in English bulldogs
Emily D. Rout, A Russell Moore, Robert C. Burnett, et al.
Journal of Veterinary Internal Medicine (2020) Vol. 34, Iss. 6, pp. 2622-2635
Open Access | Times Cited: 12
Emily D. Rout, A Russell Moore, Robert C. Burnett, et al.
Journal of Veterinary Internal Medicine (2020) Vol. 34, Iss. 6, pp. 2622-2635
Open Access | Times Cited: 12
The Landscape of IgA Nephropathy Treatment Strategy: A Pharmacological Overview
Vincenzo Di Leo, Francesca Annese, Federica Papadia, et al.
Future Pharmacology (2023) Vol. 3, Iss. 2, pp. 517-534
Open Access | Times Cited: 2
Vincenzo Di Leo, Francesca Annese, Federica Papadia, et al.
Future Pharmacology (2023) Vol. 3, Iss. 2, pp. 517-534
Open Access | Times Cited: 2
Tonsillar immunology in IgA nephropathy
Xinxin Yang, Anchao Zhu, Hongxue Meng
Pathology - Research and Practice (2020) Vol. 216, Iss. 7, pp. 153007-153007
Closed Access | Times Cited: 6
Xinxin Yang, Anchao Zhu, Hongxue Meng
Pathology - Research and Practice (2020) Vol. 216, Iss. 7, pp. 153007-153007
Closed Access | Times Cited: 6
High APRIL Levels Are Associated With Slow Disease Progression and Low Immune Activation in Chronic HIV-1-Infected Patients
Yubin Liu, Xiuxia Li, Yang Han, et al.
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 6
Yubin Liu, Xiuxia Li, Yang Han, et al.
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 6
Measurement of galactosyl-deficient IgA1 by the monoclonal antibody KM55 contributes to predicting patients with IgA nephropathy with high risk of long-term progression
Luis Martín‐Penagos, Gema Fernández‐Fresnedo, Adalberto Benito‐Hernández, et al.
Nefrología (English Edition) (2021) Vol. 41, Iss. 3, pp. 311-320
Open Access | Times Cited: 6
Luis Martín‐Penagos, Gema Fernández‐Fresnedo, Adalberto Benito‐Hernández, et al.
Nefrología (English Edition) (2021) Vol. 41, Iss. 3, pp. 311-320
Open Access | Times Cited: 6
Histological Correlation between Tonsillar and Glomerular Lesions in Patients with IgA Nephropathy Justifying Tonsillectomy: A Retrospective Cohort Study
Kensuke Joh, Hiroyuki Ueda, Kan Katayama, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5298-5298
Open Access
Kensuke Joh, Hiroyuki Ueda, Kan Katayama, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5298-5298
Open Access
Blood transcriptomic analysis reveals novel hub gene pathways associated with serum galactose-deficient IgA1 level in IgA nephropathy
Youxia Liu, Hongfen Li, Fanghao Wang, et al.
Research Square (Research Square) (2024)
Open Access
Youxia Liu, Hongfen Li, Fanghao Wang, et al.
Research Square (Research Square) (2024)
Open Access
